Blood Glucose Meters - Medical Devices Pipeline Assessment, 2020

1.1 List of Tables
1.2 List of Figures

2.1 Blood Glucose Meters Overview

3.1 Blood Glucose Meters - Pipeline Products by Stage of Development
3.2 Blood Glucose Meters - Pipeline Products by Segment
3.3 Blood Glucose Meters - Pipeline Products by Territory
3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path
3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date
3.6 Blood Glucose Meters - Ongoing Clinical Trials

4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development
4.2 Blood Glucose Meters - Pipeline Products by Stage of Development

5.1 4a Medicom GmbH Company Overview
5.1.1 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 Abbott Diabetes Care Inc Company Overview
5.2.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced Biosensors-Ohio LLC Company Overview
5.3.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Advanced Medical Electronics Corp Company Overview
5.4.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Alertgy Inc Company Overview
5.5.1 Alertgy Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Arkal Medical Inc (Inactive) Company Overview
5.6.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Arkray Inc Company Overview
5.7.1 Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Azurite Technologies, Inc. (Inactive) Company Overview
5.8.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bar-Ilan University Company Overview
5.9.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
5.10 Baylor University Company Overview
5.10.1 Baylor University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Biofi Medical Healthcare Pvt Ltd Company Overview
5.11.1 Biofi Medical Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Biopeak Corp Company Overview
5.12.1 Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 Biorasis Inc Company Overview
5.13.1 Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 BioTex Inc Company Overview
5.14.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Biovotion AG Company Overview
5.15.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
5.16 Brain Beat Ltd Company Overview
5.16.1 Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Brigham and Women's Hospital Company Overview
5.17.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.18 CALISTO MEDICAL, INC. (Inactive) Company Overview
5.18.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.19 Callitas Therapeutics Inc Company Overview
5.19.1 Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Cardiff University Company Overview
5.20.1 Cardiff University Pipeline Products & Ongoing Clinical Trials Overview
5.21 CGM3 Ltd Company Overview
5.21.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 Cirtec Medical LLC Company Overview
5.22.1 Cirtec Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 City, University of London Company Overview
5.23.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview
5.24 Columbia University Company Overview
5.24.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.25 ConvaTec Group Plc Company Overview
5.25.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Co-Optical Inc Company Overview
5.26.1 Co-Optical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Cyber Medical Ltd Company Overview
5.27.1 Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 DexCom Inc Company Overview
5.28.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 DiaMonTech GmbH Company Overview
5.29.1 DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.30 DirectSens GmbH Company Overview
5.30.1 DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.31 Echo Therapeutics Inc Company Overview
5.31.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Ecole Polytechnique Federale de Lausanne Company Overview
5.32.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
5.33 eLutions Integrated Systems, Inc. Company Overview
5.33.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.34 Emperra GmbH E-Health Technologies Company Overview
5.34.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.35 EyeSense GmbH Company Overview
5.35.1 EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.36 Firefly Health Pty Ltd Company Overview
5.36.1 Firefly Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.37 Flowsion A/S Company Overview
5.37.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview
5.38 Gili Medical Ltd Company Overview
5.38.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.39 Globe Medical Tech Inc (Inactive) Company Overview
5.39.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.40 GlucoLight Corporation (Inactive) Company Overview
5.40.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.41 GlucoMe Ltd Company Overview
5.41.1 GlucoMe Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.42 Glucometrix AG Company Overview
5.42.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview
5.43 Glucosat Company Overview
5.43.1 Glucosat Pipeline Products & Ongoing Clinical Trials Overview
5.44 Glucosense Diagnostics Ltd (Inactive) Company Overview
5.44.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.45 GlucoSet AS Company Overview
5.45.1 GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview
5.46 GlucoStats System Pte Ltd. Company Overview
5.46.1 GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.47 Glucovation Inc Company Overview
5.47.1 Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview
5.48 GluMetrics Inc Company Overview
5.48.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.49 Glusense Ltd Company Overview
5.49.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.50 GlySens Inc Company Overview
5.50.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview
5.51 G-Sense Ltd. Company Overview
5.51.1 G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.52 iGlyko, Inc. (Inactive) Company Overview
5.52.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.53 Indigo Diabetes NV Company Overview
5.53.1 Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview
5.54 InLight Solutions Inc. Company Overview
5.54.1 InLight Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.55 Innopharmax Inc Company Overview
5.55.1 Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview
5.56 Innovosens AB Company Overview
5.56.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview
5.57 Insulet Corp Company Overview
5.57.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
5.58 Integrated Medical Sensors Company Overview
5.58.1 Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview
5.59 Integrity Applications Ltd Company Overview
5.59.1 Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.60 IntelliDx Inc (Inactive) Company Overview
5.60.1 IntelliDx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.61 Invivomon Inc (Inactive) Company Overview
5.61.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.62 Invivosense ASA (Inactive) Company Overview
5.62.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.63 I-Sens Inc Company Overview
5.63.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
5.64 iSense Corporation (Inactive) Company Overview
5.64.1 iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.65 KeenCAT Technologies Company Overview
5.65.1 KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.66 Keratin Biosciences Inc Company Overview
5.66.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.67 Know Labs Inc Company Overview
5.67.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
5.68 KTH Royal Institute of Technology Company Overview
5.68.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.69 Lein Applied Diagnostics Limited Company Overview
5.69.1 Lein Applied Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
5.70 LEMM Technologies, LLC Company Overview
5.70.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.71 LifeScan Inc Company Overview
5.71.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview
5.72 LighTouch Medical, Inc. Company Overview
5.72.1 LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.73 Luminous Medical Inc (Inactive) Company Overview
5.73.1 Luminous Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.74 Lyte Labs Company Overview
5.74.1 Lyte Labs Pipeline Products & Ongoing Clinical Trials Overview
5.75 Massachusetts Institute of Technology Company Overview
5.75.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.76 Medical Wireless Sensing Ltd Company Overview
5.76.1 Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.77 Medtronic Diabetes Company Overview
5.77.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
5.78 Medtronic Plc Company Overview
5.78.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.79 Mellitor Ltd Company Overview
5.79.1 Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.80 Metronom Health Inc Company Overview
5.80.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.81 mobiLIFE Company Overview
5.81.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview
5.82 Mologic Ltd Company Overview
5.82.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.83 Movano Inc Company Overview
5.83.1 Movano Inc Pipeline Products & Ongoing Clinical Trials Overview
5.84 Nagasaki University Company Overview
5.84.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview
5.85 Nemaura Medical Inc Company Overview
5.85.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.86 Newton Photonics Inc Company Overview
5.86.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.87 NIR Diagnostics Inc. (Inactive) Company Overview
5.87.1 NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.88 Northwestern University Company Overview
5.88.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.89 Orsus Medical Ltd Company Overview
5.89.1 Orsus Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.90 Ossen Innovation Co Ltd Company Overview
5.90.1 Ossen Innovation Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.91 Pelikan Technologies, Inc. (Inactive) Company Overview
5.91.1 Pelikan Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.92 Pepex Biomedical, Inc. Company Overview
5.92.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.93 PharmaTech Solutions Inc Company Overview
5.93.1 PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.94 Pignolo SpA Company Overview
5.94.1 Pignolo SpA Pipeline Products & Ongoing Clinical Trials Overview
5.95 PKvitality SAS Company Overview
5.95.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview
5.96 POPS! Diabetes Care Inc Company Overview
5.96.1 POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.97 PositiveID Corp Company Overview
5.97.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview
5.98 Prediktor Medical AS Company Overview
5.98.1 Prediktor Medical AS Pipeline Products & Ongoing Clinical Trials Overview
5.99 Profusa Inc Company Overview
5.99.1 Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview
5.100 Purdue University Company Overview
5.100.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.101 Q Step Technologies, Inc. Company Overview
5.101.1 Q Step Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.102 Roche Diabetes Care Inc Company Overview
5.102.1 Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.103 Senseonics Holdings Inc Company Overview
5.103.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.104 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
5.104.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.105 Sensyne Health Plc Company Overview
5.105.1 Sensyne Health Plc Pipeline Products & Ongoing Clinical Trials Overview
5.106 Sensys Medical, Inc. Company Overview
5.106.1 Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.107 Sentec Pte Ltd Company Overview
5.107.1 Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.108 Senzime AB Company Overview
5.108.1 Senzime AB Pipeline Products & Ongoing Clinical Trials Overview
5.109 Shield Diagnostics Company Overview
5.109.1 Shield Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.110 Singapore Biomicro Pte Ltd Company Overview
5.110.1 Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.111 Socrates Health Solutions, Inc. Company Overview
5.111.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.112 Solys Diagnostics Inc Company Overview
5.112.1 Solys Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.113 Spire Biophotonics Lifesciences Company Overview
5.113.1 Spire Biophotonics Lifesciences Pipeline Products & Ongoing Clinical Trials Overview
5.114 St. Louis Medical Devices Inc (Inactive) Company Overview
5.114.1 St. Louis Medical Devices Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.115 Stony Brook University Company Overview
5.115.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
5.116 Swansea University Company Overview
5.116.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview
5.117 TecMed Inc Company Overview
5.117.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.118 Tenax Therapeutics Inc Company Overview
5.118.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.119 Terumo Corp Company Overview
5.119.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.120 Texas A&M University Company Overview
5.120.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
5.121 Ultradian Diagnostics LLC Company Overview
5.121.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.122 University of California Berkeley Company Overview
5.122.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
5.123 University of California Irvine Company Overview
5.123.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
5.124 University of California San Diego Company Overview
5.124.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
5.125 University of Central Florida Company Overview
5.125.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
5.126 University of South Carolina Company Overview
5.126.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
5.127 University of South Florida Company Overview
5.127.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.128 University of Technology Sydney Company Overview
5.128.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.129 University of Texas at Arlington Company Overview
5.129.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview
5.130 VeriTeQ Corporation Company Overview
5.130.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.131 Virginia Commonwealth University Company Overview
5.131.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
5.132 Vytrace, Inc. Company Overview
5.132.1 Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.133 WaveForm Technologies Inc Company Overview
5.133.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.134 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview
5.134.1 Xcellence in Bio Innovations & Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.135 Ypsomed Holding AG Company Overview
5.135.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
5.136 Zansors LLC Company Overview
5.136.1 Zansors LLC Pipeline Products & Ongoing Clinical Trials Overview
5.137 Zyvex Corp Company Overview
5.137.1 Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview

6.1 Nov 10, 2020: Delta Electronics to increase stake in Lanner
6.2 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.3 Oct 11, 2020: Delta Electronics’ Consolidated Sales Revenues for September 2020 Totaled NT$26,804 Million
6.4 Sep 08, 2020: Delta Electronics’ consolidated sales revenues for August 2020 totaled NT$25,093 Million
6.5 Aug 31, 2020: Onduo’s new prospective study published in the Journal of Medical Internet Research highlights the benefit of continuous glucose monitoring systems
6.6 Aug 10, 2020: Delta Electronics’ consolidated sales revenues for july 2020 totaled NT$25,782 million
6.7 Aug 10, 2020: Helmsley awards $5 million to evaluate virtual diabetes specialty clinic model
6.8 Jul 28, 2020: Nemaura signs letter of intent to acquire Healthimation
6.9 Jul 27, 2020: Roche contract expansion to profile autoantibodies
6.10 Jun 15, 2020: Bayer U.S announces retirement of Philip Blake
6.11 Jun 09, 2020: Medtronic announces scientific data presentations at the American Diabetes Association 80th Scientific Sessions
6.12 May 04, 2020: Delta Electronics announces 2020-Q1 financial results
6.13 Apr 27, 2020: Sanmina reports second quarter financial results
6.14 Apr 16, 2020: Abbott reports first-quarter 2020 results
6.15 Apr 09, 2020: Delta Electronics’ Consolidated Sales Revenues for March 2020 Totaled NT$21,083 Million
6.16 Mar 11, 2020: Welldoc announces collaboration with Dexcom to enhance the value of BlueStar with the Dexcom G6 CGM System
6.17 Mar 10, 2020: Nemaura Medical enters Into multiple verbal non-binding agreements for its sugarBEAT Platform
6.18 Mar 04, 2020: Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors
6.19 Mar 03, 2020: Nemaura Medical launches sugarBEAT App on play store ahead of its planned commercial launch of BEAT diabetes subscription service
6.20 Feb 28, 2020: Sensyne Health recognised for its impact in helping treat diabetes in pregnancy
6.21 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019
6.22 Feb 27, 2020: Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures
6.23 Feb 27, 2020: ConvaTec Group: Non-executive director appointment
6.24 Feb 26, 2020: Senseonics announces the FDA approval to continue the PROMISE sensor clinical study in an extended cohort to 365 days to gather feasibility data
6.25 Feb 25, 2020: Nemaura Medical plans head-to-head study with major glucose monitoring system
6.26 Feb 25, 2020: Sanofi announces resignation of Director
6.27 Feb 25, 2020: Henry Schein Named One of the 2020 World's Most Ethical Companies by Ethisphere
6.28 Feb 24, 2020: Senseonics reports at ATTD glycemic outcomes across adult age ranges with real-world Eversense CGM use
6.29 Feb 24, 2020: Advanced Hybrid Closed Loop System early feasibility data on patients undergoing unannounced meal challenges shows promising results
6.30 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.31 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.32 Feb 22, 2020: Bayer Cares Foundation donates over EUR 363,000 to support 94 social projects in 32 countries worldwide
6.33 Feb 21, 2020: Study from Ascensia demonstrates impact of BGMS selection on glycemic control when using a diabetes management app
6.34 Feb 21, 2020: Tenax announces the addition of Mayo Clinic expert, Dr. Barry Borlaug, to Scientific Advisory Board
6.35 Feb 20, 2020: New real-world data show that Abbott's FreeStyle Libre System delivers positive health outcomes for people with type 1 and type 2 diabetes
6.36 Feb 20, 2020: DECN announces market readiness of its GenUltimate TBG, adds to product's compatibility at the request of strategic partner, completes its universal translator GenExpidient! Device
6.37 Feb 20, 2020: Dexcom G6 Continuous Glucose Monitoring (CGM) System receives CE mark for use during pregnancy in the EU
6.38 Feb 20, 2020: Henry Schein reports record fourth quarter 2019 financial results from continuing operations
6.39 Feb 19, 2020: Abbott and Insulet partner on automated diabetes care
6.40 Feb 18, 2020: Senseonics announces a positive coverage decision for Eversense CGM from Cigna
6.41 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.42 Feb 13, 2020: Glooko names Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer
6.43 Feb 11, 2020: Senseonics announces partnership with Companion Medical
6.44 Feb 11, 2020: Nemaura Medical reports results and provides business update for the third quarter ended December 31, 2019
6.45 Feb 11, 2020: Henry Schein’s Steven W. Kess named President of the Santa Fe Group
6.46 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
6.47 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan
6.48 Feb 06, 2020: Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
6.49 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors
6.50 Feb 03, 2020: 3D Systems expands Sanmina relationship to provide plastic printer manufacturing -- driving greater quality, availability, and reliability while improving 3d systems’ cost structure
6.51 Jan 30, 2020: Roche reports very strong results in 2019
6.52 Jan 30, 2020: HR for Health and Henry Schein announce exclusive business relationship to provide doctors with new solutions to simplify human resources & payroll
6.53 Jan 29, 2020: UPS and Henry Schein sign agreement to explore Drone Delivery
6.54 Jan 27, 2020: Theraclion demonstrates its leadership in thyroid and veins none invasive treatments
6.55 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
6.56 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience
6.57 Jan 13, 2020: Livongo and Dexcom partner to integrate Dexcom’s G6 Continuous Glucose Monitoring System into Livongo’s Applied Health Signals Platform
6.58 Jan 09, 2020: Tandem Diabetes Care appoints new executive vice president of strategy and corporate development
6.59 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
6.60 Jan 07, 2020: Children's Choice Pediatrics Notifies Patients of Data Security Incident
6.61 Jan 02, 2020: Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020
6.62 Dec 23, 2019: Dexcom Partners with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain
6.63 Dec 20, 2019: Nemaura provides 2019 year-end corporate update
6.64 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group
6.65 Dec 18, 2019: Senzime recruits general manager to lead US operations
6.66 Dec 17, 2019: Nemaura Medical and Changing Health announce partnership to provide award-winning diabetes behavioral change services
6.67 Dec 17, 2019: Roche gets UK and US clearances for Spark Therapeutics acquisition
6.68 Dec 11, 2019: Glooko earns privacy shield certification for policies to safeguard diabetes patient data
6.69 Dec 10, 2019: Bayer to significantly step-up its sustainability efforts
6.70 Dec 09, 2019: Changes in the Board of Directors and the Corporate Executive Committee of Roche
6.71 Dec 05, 2019: Nemaura Medical announces expansion of SugarBEAT offering with BEAT Diabetes digital subscription services
6.72 Dec 04, 2019: OptiScan Biomedical announces peer-reviewed publications highlighting first-of-its-kind continuous monitoring platform for intensive care units
6.73 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.74 Dec 02, 2019: Senseonics launches Eversense CGM System with non-adjunctive claim in the U.S.

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

Table 1: Blood Glucose Meters - Pipeline Products by Stage of Development
Table 2: Blood Glucose Meters - Pipeline Products by Segment
Table 3: Blood Glucose Meters - Pipeline Products by Territory
Table 4: Blood Glucose Meters - Pipeline Products by Regulatory Path
Table 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date
Table 6: Blood Glucose Meters - Ongoing Clinical Trials
Table 7: Blood Glucose Meters Companies - Pipeline Products by Stage of Development
Table 8: Blood Glucose Meters - Pipeline Products by Stage of Development
Table 9: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: GlucoPEARL - Product Status
Table 11: GlucoPEARL - Product Description
Table 12: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Freestyle Libre 3 - Product Status
Table 14: Freestyle Libre 3 - Product Description
Table 15: Freestyle Libre Connected Insulin Pen - Product Status
Table 16: Freestyle Libre Connected Insulin Pen - Product Description
Table 17: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
Table 18: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
Table 19: Updated Hospital Blood Glucose Monitoring System - Product Status
Table 20: Updated Hospital Blood Glucose Monitoring System - Product Description
Table 21: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
Table 22: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
Table 23: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
Table 24: Freestyle Libre 3 - FreeStyle Libre 3 Continuous Glucose Monitoring System Accuracy Study
Table 25: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 26: My Medibit - Product Status
Table 27: My Medibit - Product Description
Table 28: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Continuous Glucose Monitor - Product Status
Table 30: Continuous Glucose Monitor - Product Description
Table 31: Alertgy Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Alertgy GM - Product Status
Table 33: Alertgy GM - Product Description
Table 34: Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 35: GlucoPod CGM System - Product Status
Table 36: GlucoPod CGM System - Product Description
Table 37: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: GLUCOCARD S - Product Status
Table 39: GLUCOCARD S - Product Description
Table 40: GLUCOCARD S onyx - Product Status
Table 41: GLUCOCARD S onyx - Product Description
Table 42: GLUCOCARD W - Product Status
Table 43: GLUCOCARD W - Product Description
Table 44: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Blood Glucose Sensor - Product Status
Table 46: Blood Glucose Sensor - Product Description
Table 47: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Biometric Watch - Product Status
Table 49: Biometric Watch - Product Description
Table 50: Baylor University Pipeline Products & Ongoing Clinical Trials Overview

Figure 1: Blood Glucose Meters - Pipeline Products by Stage of Development
Figure 2: Blood Glucose Meters - Pipeline Products by Segment
Figure 3: Blood Glucose Meters - Pipeline Products by Territory
Figure 4: Blood Glucose Meters - Pipeline Products by Regulatory Path
Figure 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date
Figure 6: Blood Glucose Meters - Ongoing Clinical Trials